The trajectory of Viagra, originally marketed by copyright, presents a complex case study for investors considering the healthcare landscape . While its initial success and impact of vast in sales, the intellectual property lapse has opened the door for generic medications, significantly reducing earnings opportunities. This shift raises concerns a